| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 09/13/2007 | US20070213347 [3-(4-{2-butyl-1-[4-(4chloro-phenoxy)-phenyl]-1H-imidazol-4-yl}-phenoxy)-propyl]-diethyl-amine, used as modulators of the interaction between the receptor for advanced glycated end products and its ligands; inflammation, nephropathy, atherosclerosis, retinopathy, Alzheimer's disease, erectile dysfunction |
| 09/13/2007 | US20070213344 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 09/13/2007 | US20070213343 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 09/13/2007 | US20070213342 2-1-Aza-bicyclo[2.2.2]oct-3-yl-6-phenyl-2,3-dihydro-isoindol-1-one, salts and radioactive materials for drug screening; anxiolytic agents; antidepressants; schizophrenia; cognitive activators; attention disorders; Alzheimer's disease; Parkinson's disease; Tourette's syndrome; neuroprotants; analgesics |
| 09/13/2007 | US20070213337 Modulators of serotonin receptors |
| 09/13/2007 | US20070213329 Sulphones which modulate the action of gammasecretase |
| 09/13/2007 | US20070213316 N,N'-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 09/13/2007 | US20070213294 Methods for modulating the axonal growth of central nervous system neurons |
| 09/13/2007 | US20070213254 Remedy For Diabetic Neuropathy Comprising Gelatin Gel As Carrier |
| 09/13/2007 | US20070212714 Novel genes TZap7/A, TZap7/B and TZap7 involved in T cell activation and uses thereof |
| 09/13/2007 | US20070212421 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 09/13/2007 | US20070212372 Methods for the treatment and prophylaxis of demeyelinating disease |
| 09/13/2007 | DE102006011359A1 Verwendung eines Kokain-Derivats Use of a cocaine derivative |
| 09/13/2007 | CA2645018A1 Pharmaceutical combination |
| 09/13/2007 | CA2644996A1 A2a adenosine receptor antagonists |
| 09/13/2007 | CA2644850A1 Quinoline and isoquinoline derivatives as phosphodiesterase 10 inhibitors |
| 09/13/2007 | CA2644804A1 A cyclohexane polyalcohol formulation for treatment of disorders of protein aggregation |
| 09/13/2007 | CA2644672A1 Quinazoline derivatives as phosphodiesterase 10 inhibitors |
| 09/13/2007 | CA2644280A1 Phosphodiesterase 10 inhibitors |
| 09/13/2007 | CA2643796A1 Polycyclic cinnamide derivatives |
| 09/13/2007 | CA2643362A1 Use of pyrazolo[1,5a]pyrimidin-7-yl amine derivatives in the treatment of neurological disorders |
| 09/13/2007 | CA2643350A1 Meridamycin analogues for the treatment of neurodegenerative disorders |
| 09/13/2007 | CA2642859A1 4-amino-1,5-substituted 1,5-dihydro-imidazol-2-ones |
| 09/13/2007 | CA2634133A1 An improved process for the preparation of armodafinil |
| 09/12/2007 | EP1832599A2 Albumin fusion proteins |
| 09/12/2007 | EP1832590A2 Tri- heterocyclic compounds and a pharmaceutical comprising them as an active ingredient |
| 09/12/2007 | EP1832588A1 Condensed imidazole compound and use thereof |
| 09/12/2007 | EP1832580A1 Crystal and salt of 1-cyclopropylmethyl-4-ý2-(3,3,5,5)-tetramethylcyclohexyl)phenyl¨piperazine |
| 09/12/2007 | EP1832298A1 Matrix-type controlled release preparation comprising basic substance or salt thereof, and process for production of the same |
| 09/12/2007 | EP1832286A1 Preventive or therapeutic agent for sleep disorder |
| 09/12/2007 | EP1831683A1 Methods of modulating the activities of alpha7 nicotinic acetylcholine receptor |
| 09/12/2007 | EP1831354A1 Platelet-derived growth factor-responsive neural precursor cells and progeny thereof |
| 09/12/2007 | EP1831231A1 Nicotinic acetylcholine receptor ligands |
| 09/12/2007 | EP1831229A1 Thienopyrimidine derivatives as phosphodiesterase 10 inhibitors |
| 09/12/2007 | EP1831228A1 Novel pyrazole derivatives and their use as modulators of nicotinic acetylcholine receptors |
| 09/12/2007 | EP1831212A1 Nicotinic acetycholine receptor ligands |
| 09/12/2007 | EP1831203A1 Chroman derivatives and uses thereof in the treatment of cns disorders |
| 09/12/2007 | EP1831201A1 Piperidine and azetidine derivatives as glyt1 inhibitors |
| 09/12/2007 | EP1831197A2 Substituted oxindole derivatives, medicaments containing said derivatives and use thereof |
| 09/12/2007 | EP1831195A1 5-ht7 receptor antagonists |
| 09/12/2007 | EP1831194A1 HETEROCYCLIC MCHr1 ANTAGONISTS AND THEIR USE IN THERAPY |
| 09/12/2007 | EP1831189A1 Tetralin and indane derivatives and uses thereof |
| 09/12/2007 | EP1831188A1 N-biaryl and n-arylheteroaryl 2-substituted piperazine derivatives as modulators of the 5ht2c receptor useful for the treatment of disorders related thereto |
| 09/12/2007 | EP1831185A1 Triazolone, tetrazolone and imidazolone derivatives for use as alpha-2c adrenoreceptor antagonists |
| 09/12/2007 | EP1831177A1 Therapeutic agents |
| 09/12/2007 | EP1831173A1 Tetrahydroisoquinoline compounds for treatment of cns disorders |
| 09/12/2007 | EP1831172A1 Substituted carbamic acid quinolin-6-yl esters useful as acetylcholinesterase inhibitors |
| 09/12/2007 | EP1831170A1 Substituted aminopyridines and uses thereof |
| 09/12/2007 | EP1831152A1 Tetralin and indane derivatives and uses thereof as 5-ht antagonists |
| 09/12/2007 | EP1830873A1 Glyponectin (glycosylated adiponectin) for the treatment of diseases and conditions |
| 09/12/2007 | EP1830869A1 Method of treatment or prophylaxis |
| 09/12/2007 | EP1830856A2 Preventing pathological increases in the rate of nerve cell suicide in immature nervous systems |
| 09/12/2007 | EP1830854A1 Arylpiperazine derivatives and use thereof as 5-ht1a receptor ligands |
| 09/12/2007 | EP1830844A1 Antidepressant medicament comprising idazoxan and a selective serotonin reuptake inhibitor |
| 09/12/2007 | EP1830833A2 Combination of a glycine transporter (glyt1) inhibitor and an antipsychotic for the treatment of symptoms of schizophrenia as well as its preparation and use thereof |
| 09/12/2007 | EP1830824A1 Nanoparticle composition and methods for synthesis thereof |
| 09/12/2007 | EP1689447A4 Gene transfer for regulating smooth muscle tone |
| 09/12/2007 | EP1684751B1 Use of 1-thia-dibenzo e,h azulenes for the manufacture of pharmaceutical formulations for the treatment and prevention of central nervous system diseases and disorders |
| 09/12/2007 | EP1562932B9 4-tetrazolyl-4-phenylpiperidine derivatives for treating pain |
| 09/12/2007 | EP1526860B1 Bioavailability/bioefficacy enhancing activity of cuminum cyminum and extracts and fractions thereof |
| 09/12/2007 | EP1444201B1 2-(3-sulfonylamino-2-oxopyrrolidin-1-yl)propanamides as factor xa inhibitors |
| 09/12/2007 | EP1407013B1 Mutations in ion channels |
| 09/12/2007 | EP1395566B1 Tricyclic compounds useful as angiotensin ii agonists |
| 09/12/2007 | EP1379239B1 N-(2-arylethyl) benzylamines as antagonists of the 5-ht6 receptor |
| 09/12/2007 | EP1351694B1 Promoting cell regeneration and/or cell differentiation with non-metabolizable sugar and a polymeric absorbent |
| 09/12/2007 | EP1301480B1 1,3-disubstituted and 1,3,3-trisubstituted pyrrolidines as histamine-3 receptor ligands and their therapeutic applications |
| 09/12/2007 | EP1024834B1 Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same |
| 09/12/2007 | EP0994867B1 Polymorphic form of the tachykinin receptor antagonist 2-(r)-(1-(r) -(3,5-bis(trifluoromethyl) phenyl)ethoxy)-3-(s)-(4-fluoro) phenyl-4-(3-5 (-oxo-1h,4h-1,2,4,-triazolo) methylmorpholine |
| 09/12/2007 | EP0993613B1 Method for recognizing and determining gnrh receptors and the use of gnrh agonists and gnrh antagonists and other gnrh receptor ligands for the treatment with gnrh receptors of tumours originating in the brain and/or nervous system and/or meninges and/or of kaposi sarcoma |
| 09/12/2007 | EP0842268B1 Methods and compositions for identifying morphogen analogs |
| 09/12/2007 | EP0776161B2 Use of a viral vector encoding a cytochrome p450 gene in combination with a chemotherapeutic agent for selectively destroying neoplastic cells |
| 09/12/2007 | CN101035792A Novel diazabicyclic aryl derivatives and their medical use |
| 09/12/2007 | CN101035781A 2-morpholino-4-pyrimidone compound |
| 09/12/2007 | CN101035772A 2-amino-quinazoline derivatives useful as inhibitors of beta-secretase (BACE) |
| 09/12/2007 | CN101035771A 2-amino-quinazoline derivatives useful as inhibitors of beta-secretase (BACE) |
| 09/12/2007 | CN101035768A Compounds and compositions useful as cathepsin S inhibitors |
| 09/12/2007 | CN101035765A 磺酰胺衍生物 Sulfonamide derivatives |
| 09/12/2007 | CN101035761A 3,6-substituted 5-arylamino-1h-pyridine-2-one derivatives and related compounds as poly(ADP-ribose) polymerase(PARP) inhibitors in the treatment of tissue damage or diseage caused by necrosis or apopt |
| 09/12/2007 | CN101035759A Synthesis of N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N'-(4-(2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and crystalline forms |
| 09/12/2007 | CN101035550A Composition and method for therapy or prevention of mental symptom |
| 09/12/2007 | CN101035541A Neuroprotective effect of solubilized UDCA in focal ischemic model |
| 09/12/2007 | CN101035539A Novel uses of 2-phenyl-substituted imidazotriazinone derivatives |
| 09/12/2007 | CN101035535A Use of 4-(4-methylpiperazin-1-ylmethyl)-N-[4-methyl-3-(4-(pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide to inhibit the tyrosine kinase receptor c-fms |
| 09/12/2007 | CN101035533A Dual NK1/NK3 antagonists against schizophrenia |
| 09/12/2007 | CN101032604A Chinese medicine preparation for curing vascular type headache |
| 09/12/2007 | CN101032603A Nerve impulse path wine |
| 09/12/2007 | CN101032595A Energy source capsule and the preparing method |
| 09/12/2007 | CN101032560A Chinese medicine composition for treating somnipathy and preparing method thereof |
| 09/12/2007 | CN101032559A Preparing method of Chinese traditional medicine for strengthening the spleen and the heart |
| 09/12/2007 | CN101032521A Application of seal oil in producing medicine for improving intelligence |
| 09/12/2007 | CN101032483A Composing of hydantoin ramification for adjusting estrogen receptor activity and application thereof |
| 09/12/2007 | CN101032474A Rasagiline transparent patch for curing and preventing neurological diseases and the preparing method thereof |
| 09/12/2007 | CN101032464A Combination containing rimonabant and polyvinyl pyrrolidone, solid dispersion and the preparing and medicine application thereof |
| 09/12/2007 | CN101032433A Traditional Chinese medicine magnetic therapeutic pillow |
| 09/12/2007 | CN101032267A Tea for dispelling the alcoholic intoxication |
| 09/12/2007 | CN100336833C Companumoea root polyose, derivative and its preparing method and use |
| 09/12/2007 | CN100336827C South China sea conus littertus linnaeus nervotoxin and its coding sequence and use |
| 09/12/2007 | CN100336813C Oxazoles as mGluR1 enhancer |
| 09/12/2007 | CN100336532C Oral medicinal preparation against drug addiction and its preparing method |
| 09/12/2007 | CN100336521C Composition comprising melissa leaf extract for anti-angiogenic and matrix metalloproteinase inhibitory activity |